Berlin will host targeting mitochondrial 2022

The Thirteenth International Conference on Mitochondrial Targeting This year it will be held at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany and online from October 26 to 28.

Targeting mitochondrial 2022 will bring up many hot topics related to mitochondrial function and dysfunction in health and disease. All topics will be provided by Selected speakers.

Here are some of the speaker topics related to mitochondrial targeting 2022: Mitochondrial signalsAnd the Mitochondrial diseasesAnd the cancerAnd the Cardiovascular disease (brain attack), sepsisAnd the fatty liver diseaseAnd the respiratory system diseasesAnd the schizophreniaAnd the Brain injuries and neurological diseasesAnd the agingGenetic/metabolic disorders, Extracellular vesicles and mitochondrial dysfunctionsAnd the Treatment of extracellular vesiclesAnd the Mitochondrial medicineAnd the Mitochondrial transplantAnd the Mitochondrial transportAnd the Mitochondrial genome engineeringAnd the conversion therapyAnd the Optical medicineAnd the infrared lightAnd the Mitochondria and vision…

More about the speakers and their conversations.

You can get an idea about attendees.

Among the goals of mitochondrial 2022 supportersRemedies: Peppermint, Chondrion BV, and CureMito Foundation.

Presentation of abstracts

• Deadline for short oral presentations: October 7
• Poster Submission Deadline: October 14

More details about Abstract submission.

Best Mitochondrial Photo Contest

The best mitochondrial image 2022 will be selected during the conference and the winner will receive a free registration to target mitochondria 2023.

Instructions for submitting photos.

registration

Registration for both in-person and online participation is possible. Registration details.

Deadline for early bird registration: August 31.

Targeting Mitochondrial Speakers 2022:

Douglas C. WallaceAnd the Children’s Hospital of Philadelphia, USA – Keynote Speech – Mitochondrial Medicine: Present and Future

James McCauley, Boston Children’s Hospital, USA – Recent advances in mitochondrial transplantation therapy

Jan SmitnikGondryon B, The Netherlands – Phase 2b Randomized Controlled Trial of Sonlicromanol’s KHENERGYZE in Primary Mitochondrial Diseases MELAS Spectrum Disorders: Topline Results

Laurie PullmanUniversity of the Midwest, Glendale, USA – Folic acid supplementation improves the Drosophila loss-of-function phenotype and reduces mitochondrial hydrogen peroxide levels in impaired dopaminergic neurons.

Michael WeberPresident of the European Laser Academy, Germany – Mitochondrial and imaging medicine – modern clinical applications

Mark GermanAnd the University of Quebec at Trois-Rivieres, Canada – The role of extracellular vesicles in mitochondrial quality control mechanisms

Enas, servant of GodLausanne University Hospital, Switzerland – Mitochondria, exosomal miR137-COX6A2 in Schizophrenia

Cora and changedUniversity Hospital Tübingen, Germany – Exercise and adaptations of mitochondria and fatty liver

Pedro Silva Pinheiro University of Cambridge, UK – The potential for mitochondrial genome engineering

Maria FazariUniversity of Milan, Italy – GM1 oligosaccharide as a mitochondrial modifier: implications for neurodegenerative disease

Lefkothea C PapadopoulouAnd the Aristotle University of Thessaloniki, Greece – A novel PTD-mediated IVT-mRNA delivery platform developed for protein replacement therapy of genetic/metabolic disorders

Devika S ManikamAnd the Duquesne University, USA – EV-Mitochondria as a promising treatment for mitochondrial dysfunction

Jessica SpinelliWhitehead Institute for Biomedical Research, USA – Unlocking the potential of the electron transport chain in mammals

Mark JeschkeUniversity of Toronto, Canada – Mitochondrial responses to massive shock determined for survival

Ian J HoltBiodonostia Institute for Health Research, Spain – 2-Deoxy-D-glucose pairs mitochondrial DNA replication with mitochondrial fitness

Michael TeitelAnd the University of California, USA – Mitochondrial transfer via MitoPunch

Raghavan Pillai RajuAnd the Medical College of Georgia, USA – Targeting mitochondria in aging and injury

Camila VolAnd the University of Padova, Italy – The multiple facets of the mitochondrial-forming protein Opa1 in adipocytes: from epigenetic to histological plasticity.

Kon Sophia Zhang, Loyola University Chicago Campus for Health Sciences, USA – Regulation of mitochondrial signaling in cardiomyopathy during sepsis

Julia A VoorholtETH Zurich, Switzerland – Transplantation of mitochondria between living cells

Big ArnoldMemorial Sloan Kettering Cancer Center, USA – The uncharacterized carboxylic acid cycle determines cellular identity

Mike Hotman, Wayne State University, USA – Noninvasive treatment of cerebral ischemia-reperfusion injury with near-infrared light: work on clinical implementation

Melanie Walker University of Washington College of Medicine, USA – Autologous mitochondrial transplantation for cerebral ischemia

Anna KrasnodemskayaQueen’s University Belfast, UK – Effect of mesenchymal extracellular vesicles on mitochondrial dysfunction in acute respiratory distress syndrome

Nicole Noreen HoughtonNational Institutes of Health, USA – Mitochondria in extracellular vesicles and aging

Diane Chandra Roswell Park Comprehensive Cancer Center, USA – Targeting the unfolded mitochondrial response to protein in prostate cancer

John Paulfrom the National Institute of Health, USA – Mitochondria in the photoreceptors in the retina: More than meets the eye

More about the speakers and their conversations.

About the World Mitochondrial Society:

The World Mitochondrial Society has emerged seamlessly from a series of annual conferences organized since 2010 by the International Society of Antioxidants in Nutrition and Health. The current chair of WMS is Volkmar Weissig, Midwestern University, Glendale School of Pharmacy, USA.

For more information visit the WMS website: www.wms-site.com.